Mingming Yang

Title: Innovations and Contributions of Inventor Mingming Yang

Introduction

Mingming Yang is a notable inventor based in Tianjin, China. He has made significant contributions to the field of biotechnology, particularly in the development of immunogenic compositions and fusion proteins. With a total of 3 patents, his work has the potential to impact public health positively.

Latest Patents

Mingming Yang's latest patents include a fusion protein and a construction method and use thereof. This invention provides a fusion protein that serves as a protein vehicle for a polysaccharide-protein conjugate vaccine, thereby increasing the immunogenicity of a polysaccharide antigen. Another significant patent is an immunogenic composition for preventing pneumococcal diseases. This composition comprises PspA-MRX1, PspA-EF5668, PspA-EF3296, and PlyL460D, with each component's amount ranging from 10-100 µg/ml. The preparation method involves adding the corresponding dosages of the four stock solutions to aluminum adjuvant and mixing them homogeneously. This immunogenic composition can prevent infection and invasion by covering more than 95% of the strains found in clinical settings. Its simple preparation method, low production cost, and short production cycle make it suitable for large-scale industrial production.

Career Highlights

Mingming Yang is currently associated with CanSino Biologics Inc., a company known for its innovative approaches in vaccine development. His work at the company has been instrumental in advancing research in immunology and vaccine technology.

Collaborations

Mingming Yang has collaborated with notable colleagues, including Zhongqi Shao and Tao Zhu. Their combined expertise has contributed to the successful development of innovative solutions in the field of biotechnology.

Conclusion

Mingming Yang's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work has the potential to enhance vaccine efficacy and public health outcomes.